Mesenchymal Stromal Cells Preconditioning: A New Strategy to Improve Neuroprotective Properties

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2022 Feb 26

PMID 35216215

Authors

Giovanni Schepici

Agnese Gugliandolo

Emanuela Mazzon

Affiliations

Soon will be listed here.

Abstract

Neurological diseases represent one of the main causes of disability in human life. Consequently, investigating new strategies capable of improving the quality of life in neurological patients is necessary. For decades, researchers have been working to improve the efficacy and safety of mesenchymal stromal cells (MSCs) therapy based on MSCs' regenerative and immunomodulatory properties and multilinear differentiation potential. Therefore, strategies such as MSCs preconditioning are useful to improve their application to restore damaged neuronal circuits following neurological insults. This review is focused on preconditioning MSCs therapy as a potential application to major neurological diseases. The aim of our work is to summarize both the in vitro and in vivo studies that demonstrate the efficacy of MSC preconditioning on neuronal regeneration and cell survival as a possible application to neurological damage.

Citing Articles

Hypoxic Preconditioning Prevents Oxidative Stress-Induced Cell Death in Human Hair Follicle Stem Cells.

Salehi M, Changiz Khani F, Ansari S, Mokhtari M, Dara M, Bayat M Iran J Biotechnol. 2024; 22(3):e3888.

PMID: 39737203 PMC: 11682525. DOI: 10.30498/ijb.2024.447077.3888.

Extracellular vesicles for delivering therapeutic agents in ischemia/reperfusion injury.

Zhou W, Jiang X, Gao J Asian J Pharm Sci. 2024; 19(6):100965.

PMID: 39640057 PMC: 11617990. DOI: 10.1016/j.ajps.2024.100965.

The Therapeutic Potential of Exosomes from Mesenchymal Stem Cells in Multiple Sclerosis.

Krakenes T, Sandvik C, Ytterdal M, Gavasso S, Evjenth E, Bo L Int J Mol Sci. 2024; 25(19).

PMID: 39408622 PMC: 11477223. DOI: 10.3390/ijms251910292.

Dimethyl Fumarate Preconditioning can Reinforce the Therapeutic Potential of Bone Marrow Mesenchymal Stem Cells through Trophic Factor Profile Enhancement.

Pandamooz S, Safari A, Ghorbani N, Jamhiri I, Zare S, Belem-Filho I Adv Biomed Res. 2024; 13:37.

PMID: 39224404 PMC: 11368223. DOI: 10.4103/abr.abr_298_23.

The Therapeutic Mechanisms of Mesenchymal Stem Cells in MS-A Review Focusing on Neuroprotective Properties.

Gavasso S, Krakenes T, Olsen H, Evjenth E, Ytterdal M, Haugsoen J Int J Mol Sci. 2024; 25(3).

PMID: 38338644 PMC: 10855165. DOI: 10.3390/ijms25031365.

References

Sart S, Ma T, Li Y . Preconditioning stem cells for in vivo delivery. Biores Open Access. 2014; 3(4):137-49. PMC: 4120806. DOI: 10.1089/biores.2014.0012. View

Tao H, Chen X, Wei A, Song X, Wang W, Liang L . Comparison of Teratoma Formation between Embryonic Stem Cells and Parthenogenetic Embryonic Stem Cells by Molecular Imaging. Stem Cells Int. 2018; 2018:7906531. PMC: 5889892. DOI: 10.1155/2018/7906531. View

Gugliandolo A, Diomede F, Scionti D, Bramanti P, Trubiani O, Mazzon E . The Role of Hypoxia on the Neuronal Differentiation of Gingival Mesenchymal Stem Cells: A Transcriptional Study. Cell Transplant. 2019; 28(5):538-552. PMC: 7103605. DOI: 10.1177/0963689718814470. View

Vizoso F, Eiro N, Cid S, Schneider J, Perez-Fernandez R . Mesenchymal Stem Cell Secretome: Toward Cell-Free Therapeutic Strategies in Regenerative Medicine. Int J Mol Sci. 2017; 18(9). PMC: 5618501. DOI: 10.3390/ijms18091852. View

von Bahr L, Batsis I, Moll G, Hagg M, Szakos A, Sundberg B . Analysis of tissues following mesenchymal stromal cell therapy in humans indicates limited long-term engraftment and no ectopic tissue formation. Stem Cells. 2012; 30(7):1575-8. DOI: 10.1002/stem.1118. View

Kim Y, Noh M, Cho K, Kim H, Kwon M, Kim K . Hypoxia/Reoxygenation-Preconditioned Human Bone Marrow-Derived Mesenchymal Stromal Cells Rescue Ischemic Rat Cortical Neurons by Enhancing Trophic Factor Release. Mol Neurobiol. 2014; 52(1):792-803. DOI: 10.1007/s12035-014-8912-5. View

Zhang Q, Liu S, Li T, Yuan L, Liu H, Wang X . Preconditioning of bone marrow mesenchymal stem cells with hydrogen sulfide improves their therapeutic potential. Oncotarget. 2016; 7(36):58089-58104. PMC: 5295414. DOI: 10.18632/oncotarget.11166. View

Zhang Z, Alexanian A . Dopaminergic-like cells from epigenetically reprogrammed mesenchymal stem cells. J Cell Mol Med. 2012; 16(11):2708-14. PMC: 4118239. DOI: 10.1111/j.1582-4934.2012.01591.x. View

Ferroni L, Gardin C, Tocco I, Epis R, Casadei A, Vindigni V . Potential for neural differentiation of mesenchymal stem cells. Adv Biochem Eng Biotechnol. 2012; 129:89-115. DOI: 10.1007/10_2012_152. View

10.

Urrutia D, Caviedes P, Mardones R, Minguell J, Vega-Letter A, Jofre C . Comparative study of the neural differentiation capacity of mesenchymal stromal cells from different tissue sources: An approach for their use in neural regeneration therapies. PLoS One. 2019; 14(3):e0213032. PMC: 6437714. DOI: 10.1371/journal.pone.0213032. View

11.

Eleuteri S, Fierabracci A . Insights into the Secretome of Mesenchymal Stem Cells and Its Potential Applications. Int J Mol Sci. 2019; 20(18). PMC: 6770239. DOI: 10.3390/ijms20184597. View

12.

Zhou L, Lin Q, Wang P, Yao L, Leong K, Tan Z . Enhanced neuroprotective efficacy of bone marrow mesenchymal stem cells co-overexpressing BDNF and VEGF in a rat model of cardiac arrest-induced global cerebral ischemia. Cell Death Dis. 2017; 8(5):e2774. PMC: 5520708. DOI: 10.1038/cddis.2017.184. View

13.

Bongso A, Fong C, Gauthaman K . Taking stem cells to the clinic: Major challenges. J Cell Biochem. 2008; 105(6):1352-60. DOI: 10.1002/jcb.21957. View

14.

Berebichez-Fridman R, Montero-Olvera P . Sources and Clinical Applications of Mesenchymal Stem Cells: State-of-the-art review. Sultan Qaboos Univ Med J. 2019; 18(3):e264-e277. PMC: 6307657. DOI: 10.18295/squmj.2018.18.03.002. View

15.

Wei X, Yang X, Han Z, Qu F, Shao L, Shi Y . Mesenchymal stem cells: a new trend for cell therapy. Acta Pharmacol Sin. 2013; 34(6):747-54. PMC: 4002895. DOI: 10.1038/aps.2013.50. View

16.

Ezashi T, Das P, Roberts R . Low O2 tensions and the prevention of differentiation of hES cells. Proc Natl Acad Sci U S A. 2005; 102(13):4783-8. PMC: 554750. DOI: 10.1073/pnas.0501283102. View

17.

Paul G, Anisimov S . The secretome of mesenchymal stem cells: potential implications for neuroregeneration. Biochimie. 2013; 95(12):2246-56. DOI: 10.1016/j.biochi.2013.07.013. View

18.

Ma H, Lam P, Wai Tong C, Lo K, Wong G, Poon W . The neuroprotection of hypoxic adipose tissue-derived mesenchymal stem cells in experimental traumatic brain injury. Cell Transplant. 2019; 28(7):874-884. PMC: 6719502. DOI: 10.1177/0963689719855624. View

19.

Chang C, Chio C, Cheong C, Chao C, Cheng B, Lin M . Hypoxic preconditioning enhances the therapeutic potential of the secretome from cultured human mesenchymal stem cells in experimental traumatic brain injury. Clin Sci (Lond). 2012; 124(3):165-76. DOI: 10.1042/CS20120226. View

20.

Saparov A, Ogay V, Nurgozhin T, Jumabay M, Chen W . Preconditioning of Human Mesenchymal Stem Cells to Enhance Their Regulation of the Immune Response. Stem Cells Int. 2016; 2016:3924858. PMC: 5086389. DOI: 10.1155/2016/3924858. View